A pilot study showing associations between frequency of CD4+ memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes

Publication date: Available online 22 April 2016
Source:Clinical Immunology
Author(s): Rosita Moya, Hannah Kathryn Robertson, Dawson Payne, Aditi Narsale, Jim Koziol, Joanna Davida Davies
In some patients with type 1 diabetes the dose of insulin required to achieve euglycemia is substantially reduced soon after diagnosis. This partial remission is associated with β-cell function and good glucose control. The purpose of this study was to assess whether frequencies of CD4⁺ T cell subsets in children newly diagnosed with type 1 diabetes are associated with length of partial remission. We found that the frequency of CD4⁺ memory cells, activated Treg cells and CD25⁺ cells that express a high density of the IL-7 receptor, CD127 (CD127^hi) are strongly associated with length of partial remission. Prediction of length of remission via Cox regression is significantly enhanced when CD25⁺ CD127^hi cell frequency is combined with either Insulin Dependent Adjusted A1c (IDAA1c), or glycosylated hemoglobin (HbA1c), or C-peptide levels at diagnosis. CD25⁺ CD127^hi cells do not express Foxp3, LAG-3 and CD49b, indicating that they are neither Treg nor Tr1 cells.



from #ENT via xlomafota13 on Inoreader http://ift.tt/1YN9Kdm
via IFTTT